Trial Information

Summary: Immune Studies in Chronic Myelogenous Leukemia (CML)

You have been asked to participate in this research study because you either have been diagnosed with chronic myelogenous leukemia (CML), a disease involving blood cells, OR are a potential stem cell donor for a patient with CML.  The purpose of this study is to determine how immune cells from individuals with CML interact with leukemic cells in order to develop a vaccine against CML cells.  Your participation in this study is expected to last only for the period of obtaining samples, although it is possible that additional samples will be requested. It is anticipated that a total of approximately 10-20 subjects per year will participate in this study.

Patient Inclusion/Exclusion Criteria:

- See http://clinicaltrials.coh.org for additional information.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: July 7, 2008 at 3:15:16 PM